Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

PROCEPT BioRobotics (PRCT) Operating Income (2020 - 2026)

PROCEPT BioRobotics has reported Operating Income over the past 7 years, most recently at -$32.6 million for Q1 2026.

  • Quarterly Operating Income fell 18.84% to -$32.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$109.0 million through Mar 2026, down 13.1% year-over-year, with the annual reading at -$103.9 million for FY2025, 7.5% down from the prior year.
  • Operating Income was -$32.6 million for Q1 2026 at PROCEPT BioRobotics, down from -$31.0 million in the prior quarter.
  • Over five years, Operating Income peaked at -$15.7 million in Q1 2022 and troughed at -$32.6 million in Q1 2026.
  • The 5-year median for Operating Income is -$25.6 million (2023), against an average of -$24.9 million.
  • Year-over-year, Operating Income tumbled 80.7% in 2023 and then surged 33.32% in 2024.
  • A 5-year view of Operating Income shows it stood at -$25.0 million in 2022, then dropped by 18.04% to -$29.6 million in 2023, then surged by 33.32% to -$19.7 million in 2024, then tumbled by 57.49% to -$31.0 million in 2025, then dropped by 5.04% to -$32.6 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Operating Income are -$32.6 million (Q1 2026), -$31.0 million (Q4 2025), and -$23.2 million (Q3 2025).